Table III.
Effect of Pre-Conceptional IVIG in IVF Failure Patients Positive for Autoantibodies and/or Elevated NK Cell Activity
| IVIG (N = 44)a | Control (N = 17)b | |
|---|---|---|
| Average age | 37.5 | 36.5 |
| Number of IVF failures | 4.01 | 3.18 |
| Number of embryos transferred | 5.1 | 5.2 |
| Number of clinical pregnancies | 31 (70.5%) | 11 (64.7%) |
| Number of multiple pregnancies | 3 | 1 |
| Number ongoing pregnancies | 27 (87.1%) | 1 (9.1%) |
| One or more live births/number of patients | 27/31 (87.1%) | 1/11 (9.1%) |
| Number of “take-home babies”/number of embryos transfered | 27/157 (18%) | 1/57 (2%) |
| Take-home babies per patient | 30/31 (96.7%) | 1/11 (9.1%) |
aPatients received 0.2 g/kg Venoglobin-S or Gamimune-N IVIG prior to oocyteretrieval and every 4 weeks until the third trimester.bPatients who refused treatment.